A review of 33 randomized trials
The researchers brought together 33 randomized controlled trials evaluating resilience interventions in patients with cancer. Their question concerned the effects of these interventions on stress-related health, not on cancer treatment itself.
The literature search covered five bibliographic databases, supplemented by a manual search in Google Scholar. Two researchers independently assessed the trials’ risk of bias using the Cochrane RoB 2 tool. The abstract provided does not specify the comparators, program duration or length of follow-up.
Often favorable findings, but no quantifiable effect size
The trials reported 70 outcome measures. Of the 19 measures concerning depression, 12 showed a statistically significant reduction after the intervention. For anxiety, this was the case for 16 out of 21 measures.
Quality of life improved significantly on 23 out of 26 measures. Perceived stress decreased on 3 out of 4 measures. These counts refer to measured outcomes, not proportions of patients who improved or necessarily distinct trials.
A statistically significant difference does not, by itself, tell you whether the improvement matters in everyday life. The abstract provides no overall estimate of effect size.
Why the conclusion remains cautious
Most trials raised methodological concerns or had a high risk of bias. The interventions also differed in their content, delivery method and how outcomes were reported. This heterogeneity prevented a quantitative synthesis.
The review therefore cannot identify any specific program as superior to the others. Nor does the abstract allow us to determine whether the improvements persist over time.
What this review changes
These findings support further study of resilience interventions as non-pharmacological support in cancer care. They do not demonstrate an effect on the course of cancer and cannot be directly extrapolated to people without cancer.
For you, the useful point is this distinction: a favorable signal for well-being is neither proof of lasting benefit nor an endorsement of every program claimed to build resilience.
Limitations to keep in mind
Only the PubMed abstract was consulted, not the full text. The comparators, durations, adverse effects and magnitude of benefits are not detailed in the excerpt. Most trials raise methodological concerns or have a high risk of bias. Funding and conflicts of interest were not checked.
What we can take away
Resilience interventions appear helpful for the well-being of some patients with cancer, but this review does not allow the benefit to be quantified or a specific program to be chosen.
Sources and provenance
- Resilience interventions for stress-related health outcomes in patients with cancer: Findings from a systematic review of randomized controlled trials.
Source date: 2026-10-12.
Journal Article, Systematic Review, Review · Résumé PubMed uniquement, texte intégral non consulté